Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations.

Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations.

INTRODUCTION: Before the introduction of the heptavalent pneumococcal conjugate vaccine (Prevnar-7), the relative prevalence of serotypes of Streptococcus pneumoniae was fairly stable worldwide. We sought to develop a statistical tool to predict the relative frequency of different serotypes among di...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Weinberger, D, Harboe, Z, Flasche, S, Scott, J, Lipsitch, M
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2011

Παρόμοια τεκμήρια

Estimating the contribution of different age strata to vaccine serotype pneumococcal transmission in the pre vaccine era: a modelling study
ανά: Stefan Flasche, κ.ά.
Έκδοση: (2020-06-01)

Pediatric invasive pneumococcal disease caused by vaccine serotypes following the introduction of conjugate vaccination in Denmark.
ανά: Zitta B Harboe, κ.ά.
Έκδοση: (2013-01-01)

The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination
ανά: Hans-Christian Slotved, κ.ά.
Έκδοση: (2016-11-01)

The serotype distribution among healthy carriers before vaccination is essential for predicting the impact of pneumococcal conjugate vaccine on invasive disease.
ανά: Stefan Flasche, κ.ά.
Έκδοση: (2015-04-01)

Invasive pneumococcal disease in relation to vaccine type serotypes
ανά: Paeton L. Wantuch, κ.ά.
Έκδοση: (2019-04-01)

Changing trends in serotypes of S. pneumoniae isolates causing invasive and non-invasive diseases in unvaccinated population in Mexico (2000-2014)
ανά: María Noemí Carnalla-Barajas, κ.ά.
Έκδοση: (2017-05-01)

Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis.
ανά: Weinberger, D, κ.ά.
Έκδοση: (2010)

Pneumococcal capsular polysaccharide structure predicts serotype prevalence.
ανά: Daniel M Weinberger, κ.ά.
Έκδοση: (2009-06-01)

Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study.
ανά: Stefan Flasche, κ.ά.
Έκδοση: (2011-04-01)

Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project.
ανά: Hope L Johnson, κ.ά.
Έκδοση: (2010-10-01)

Impact of pneumococcal conjugate vaccine in children on the serotypic epidemiology of adult invasive pneumococcal diseases in Taiwan
ανά: Hsiao-Chun Chi, κ.ά.
Έκδοση: (2018-06-01)

Pneumococcal serotypes and serogroups causing invasive disease in Pakistan, 2005-2013.
ανά: Sadia Shakoor, κ.ά.
Έκδοση: (2014-01-01)

Effect of Childhood Pneumococcal Conjugate Vaccination on Invasive Disease Serotypes in Serbia
ανά: Nataša Opavski, κ.ά.
Έκδοση: (2024-08-01)

Follow-Up Study of Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against All-Type and Serotype-Specific Invasive Pneumococcal Disease, Denmark
ανά: Katrine Finderup Nielsen, κ.ά.
Έκδοση: (2024-06-01)

Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes.
ανά: Albert Jan van Hoek, κ.ά.
Έκδοση: (2012-01-01)

Invasive pneumococcal disease caused by non-vaccine Streptococcus pneumoniae serotype 24B in an immunocompetent child
ανά: Naotaka Tamai, MD, κ.ά.
Έκδοση: (2024-04-01)

Childhood invasive pneumococcal disease caused by non-7-valent pneumococcal vaccine (PCV7) serotypes under partial immunization in Taiwan
ανά: Ching-Fen Shen, κ.ά.
Έκδοση: (2013-09-01)

Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children
ανά: Josiah Ryman, κ.ά.
Έκδοση: (2024-12-01)

Serotypes and Genotypes of Streptococcus pneumoniae in an Unvaccinated Population in Suzhou, China
ανά: Huo X, κ.ά.
Έκδοση: (2024-09-01)

Streptococcus pneumoniae serotypes/serogroups causing invasive disease in Riyadh, Saudi Arabia : Extent of coverage by pneumococcal vaccines
ανά: Al-Mazrou Abdulrahman, κ.ά.
Έκδοση: (2005-01-01)

Increase in incidence of invasive pneumococcal disease caused by serotype 3 in children eight years after the introduction of the pneumococcal conjugate vaccine in Hong Kong
ανά: Pak-Leung Ho, κ.ά.
Έκδοση: (2019-02-01)

Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.
ανά: Mark van der Linden, κ.ά.
Έκδοση: (2015-01-01)

Estimating rates of carriage acquisition and clearance and competitive ability for pneumococcal serotypes in Kenya with a Markov transition model.
ανά: Lipsitch, M, κ.ά.
Έκδοση: (2012)

Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey
ανά: Ayşe Büyükcam, κ.ά.
Έκδοση: (2017-08-01)

Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan.
ανά: Reiko Shimbashi, κ.ά.
Έκδοση: (2019-01-01)

Invasive pneumococcal disease in persons with predisposing factors is dominated by non-vaccine serotypes in Southwest Sweden
ανά: Karin Bergman, κ.ά.
Έκδοση: (2021-08-01)

Public health impact of pneumococcal conjugate vaccine infant immunization programs: assessment of invasive pneumococcal disease burden and serotype distribution
ανά: Patricia Izurieta, κ.ά.
Έκδοση: (2018-06-01)

Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Severe Invasive Disease Caused by Serotype 3 Streptococcus Pneumoniae in Italian Children
ανά: Lorenzo Lodi, κ.ά.
Έκδοση: (2019-09-01)

Serotype 3 remains the leading cause of invasive pneumococcal disease in adults in Portugal (2012-2014) despite continued reductions in other 13-valent conjugate vaccine serotypes.
ανά: Andreia N Horácio, κ.ά.
Έκδοση: (2016-10-01)

Selective and genetic constraints on pneumococcal serotype switching.
ανά: Nicholas J Croucher, κ.ά.
Έκδοση: (2015-03-01)

Systematic Literature Review of the Epidemiological Characteristics of Pneumococcal Disease Caused by the Additional Serotypes Covered by the 20-Valent Pneumococcal Conjugate Vaccine
ανά: Estelle Méroc, κ.ά.
Έκδοση: (2023-07-01)

Predicting vaccine effectiveness against invasive pneumococcal disease in children using immunogenicity data
ανά: Josiah Ryman, κ.ά.
Έκδοση: (2022-11-01)

Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.
ανά: Daniel R Feikin, κ.ά.
Έκδοση: (2013-01-01)

Conjugate vaccine serotypes persist as major causes of non-invasive pneumococcal pneumonia in Portugal despite declines in serotypes 3 and 19A (2012-2015).
ανά: Andreia N Horácio, κ.ά.
Έκδοση: (2018-01-01)

Clonal and serotype dynamics of serogroup 6 isolates causing invasive pneumococcal disease in Portugal: 1999-2012.
ανά: Jorge Diamantino-Miranda, κ.ά.
Έκδοση: (2017-01-01)

Optimal serotype compositions for Pneumococcal conjugate vaccination under serotype replacement.
ανά: Markku Nurhonen, κ.ά.
Έκδοση: (2014-02-01)

A pediatric case series of invasive pneumococcal disease caused by S.Pneumonia serotype-19A despite full dose vaccination
ανά: Burcu Ceylan Cura Yayla, κ.ά.
Έκδοση: (2023-08-01)

SEROTYPE-INDEPENDENT VACCINES AGAINST PNEUMOCOCCAL INFECTION
ανά: I. B. Semenova, κ.ά.
Έκδοση: (2016-08-01)

Serotype transition in invasive pneumococcal infection in postvaccine era
ανά: Wen-Chan Huang
Έκδοση: (2015-06-01)

Impact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children
ανά: Cebile Lekhuleni, κ.ά.
Έκδοση: (2024-09-01)